Imperagen has secured a £5 million seed round to revolutionize enzyme engineering, paving the way for significant advancements in the field. This investment will enable the company to further develop its innovative technology, driving breakthroughs in enzyme design and production. With this funding, Imperagen is poised to make a substantial impact on various industries, including pharmaceuticals and biotechnology. Read more...
Hashtags: #EnzymeEngineering #BiotechInvestment #SeedFunding #NewsWave